» Articles » PMID: 33039424

Development and Validation of a Deep Learning Algorithm for Auto-delineation of Clinical Target Volume and Organs at Risk in Cervical Cancer Radiotherapy

Overview
Journal Radiother Oncol
Specialties Oncology
Radiology
Date 2020 Oct 11
PMID 33039424
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The delineation of the clinical target volume (CTV) is a crucial, laborious and subjective step in cervical cancer radiotherapy. The aim of this study was to propose and evaluate a novel end-to-end convolutional neural network (CNN) for fully automatic and accurate CTV in cervical cancer.

Methods: A total of 237 computed tomography (CT) scans of patients with locally advanced cervical cancer were collected and evaluated. A novel 2.5D CNN network, called DpnUNet, was developed for CTV delineation and further applied for CTV and organ-at-risk (OAR) delineation simultaneously. Comprehensive comparisons and experiments were performed. The mean Dice similarity coefficient (DSC), 95th percentile Hausdorff distance (95HD) and subjective evaluation were used to assess the performance of this method.

Results: The mean DSC and 95HD values were 0.86 and 5.34 mm for the delineated CTVs. The clinical experts' subjective assessments showed that 90% of the predicted contours were acceptable for clinical usage. The mean DSC and 95HD values were 0.91 and 4.05 mm for bladder, 0.85 and 2.16 mm for bone marrow, 0.90 and 1.27 mm for left femoral head, 0.90 and 1.51 mm for right femoral head, 0.82 and 4.29 mm for rectum, 0.85 and 4.35 mm for bowel bag, 0.82 and 4.96 mm for spinal cord respectively. The average delineation time for one patient's CT images was within 15 seconds.

Conclusion: The experimental results demonstrate that the CTV and OARs delineated for cervical cancer by DpnUNet was in close agreement with the ground truth. DpnUNet could significantly reduce the radiation oncologists' contouring time.

Citing Articles

Development and validation of a deep reinforcement learning algorithm for auto-delineation of organs at risk in cervical cancer radiotherapy.

Yucheng L, Lingyun Q, Kainan S, Yongshi J, Wenming Z, Jieni D Sci Rep. 2025; 15(1):6800.

PMID: 40000766 PMC: 11861648. DOI: 10.1038/s41598-025-91362-9.


Cer-ConvN3Unet: an end-to-end multi-parametric MRI-based pipeline for automated detection and segmentation of cervical cancer.

Xia S, Zhao B, Li Y, Kong X, Wang Z, Yang Q Eur Radiol Exp. 2025; 9(1):20.

PMID: 39966210 PMC: 11836247. DOI: 10.1186/s41747-025-00557-2.


New rectum dose surface mapping methodology to identify rectal subregions associated with toxicities following prostate cancer radiotherapy.

Bouzaki A, Green D, Van Herk M, Shortall J, Puri T, Kerns S Phys Imaging Radiat Oncol. 2025; 33:100701.

PMID: 39927213 PMC: 11803856. DOI: 10.1016/j.phro.2025.100701.


Evaluating the dosimetric impact of deep-learning-based auto-segmentation in prostate cancer radiotherapy: Insights into real-world clinical implementation and inter-observer variability.

Arjmandi N, Mosleh-Shirazi M, Mohebbi S, Nasseri S, Mehdizadeh A, Pishevar Z J Appl Clin Med Phys. 2024; 26(3):e14569.

PMID: 39616629 PMC: 11905246. DOI: 10.1002/acm2.14569.


Constructing a Classification Model for Cervical Cancer Tumor Tissue and Normal Tissue Based on CT Radiomics.

Pei J, Yu J, Ge P, Bao L, Pang H, Zhang H Technol Cancer Res Treat. 2024; 23:15330338241298554.

PMID: 39539120 PMC: 11562001. DOI: 10.1177/15330338241298554.